Not finding it? Sign in to also search OpenAlex live.
-
P326 Reasons for and effectiveness of switching back to originator infliximab after a prior switch to CT-P13 biosimilar2020 Journal of Crohn s and Colitis conference-abstract Immunology and Microbiology Biosimilars and Bioanalytical Methods
Shaden Mahmmod, Johannes P. D. Schultheiss, Adriaan C.I.T.L. Tan, Maurice W. M. D. Lutgens, Lennard P. L. Gilissen, Nofel Mahmmod, +5 more
3citations -
Characteristics of High-Risk Polycythemia Vera Patients with Suboptimal Response to First-Line Therapy Who Switched to Ruxolitinib Vs Those Who Did Not Switch: Findings from PV-Switch, a Multinational, Retrospective Chart Review Study
Steffen Koschmieder, Eyck von der Heyde, Lambert Busque, Françoise Boyer‐Perrard, Timothy Devos, Francesco Passamonti, +9 more
1citations -
Transient Solid Oxide Cell Reactor Model Used in rSOC Mode-Switching Analysis and Power Split Control of an SOFC-Battery Hybrid2023 ECS Meeting Abstracts conference-abstract Materials Science Advancements in Solid Oxide Fuel Cells
Santiago Salas Ventura, Matthias Metten, Marius Tomberg, Dirk Ullmer, Cem Ünlübayir, Marc Philipp Heddrich, +1 more
0citations -
Rusfertide or placebo plus current standard-of-care therapy for polycythemia vera: Durability of response and safety results through week 52 from the randomized controlled phase 3 VERIFY study2025 Blood conference-abstract Medicine Myeloproliferative Neoplasms: Diagnosis and Treatment Open access
Andrew Tucker Kuykendall, Aniket Bankar, Kristen Marie Pettit, Joseph James Shatzel, Alessandro Lucchesi, Valentín García‐Gutiérrez, +20 more
3citations -
MO514: Cardiorenal Outcomes Associated With Oral Anticoagulant Use in Patients With Atrial Fibrillation2022 Nephrology Dialysis Transplantation conference-abstract Medicine Atrial Fibrillation Management and Outcomes
Faizan Mazhar, Marco Trevisan, Paul Hjemdahl, Catherine M. Clase, Ype de Jong, Marie Evans, +3 more
0citations -
Post Hoc Analysis of the Effect of Pegcetacoplan Treatment of Patients with Paroxysmal Nocturnal Hemoglobinuria and Baseline Hemoglobin Levels Greater Than 10 Grams per Deciliter2021 Blood conference-abstract Immunology and Microbiology Complement system in diseases Open access
Jens Panse, Nicolas Daguindau, Sonia Okuyama, Régis Peffault de Latour, Philippe Schafhausen, Nicole Straetmans, +5 more
1citations -
POS0155 CHOICE AND EFFECTIVENESS OF SECOND DMARDS AFTER MTX: COMPARING BIOLOGICAL, TARGETED, AND CONVENTIONAL OPTIONS IN EUROPEAN RA COHORTS2025 Annals of the Rheumatic Diseases conference-abstract Medicine Rheumatoid Arthritis Research and Therapies Open access
D. Di Giuseppe, Nils Steinz, J. Sexton, C.A. Hana, H. Lechner-Radner, D. Sieghart, +3 more
0citations -
P0723 Lengthening ustekinumab treatment intervals from every 8 to every 12 weeks in IBD patients in stable remission: preliminary results of a prospective observational cohort study2025 Journal of Crohn s and Colitis conference-abstract Biochemistry, Genetics and Molecular Biology Inflammatory Bowel Disease Open access
Anne B. Fons, Sander van der Marel, Rosaline Theeuwen, F Van Schaik, Mark Löwenberg, Marijn Caroline Visschedijk, +4 more
0citations -
MOTION: A randomized, phase 3, placebo-controlled, double-blind study of vimseltinib (DCC-3014) for the treatment of tenosynovial giant cell tumor.2022 Journal of Clinical Oncology conference-abstract Medicine Musculoskeletal synovial abnormalities and treatments cited by 11 patents
William D. Tap, Andrew J. Wagner, Maitreyi G. Sharma, Marc Vallee, Mary F. Michenzie, Matthew Leigh Sherman, +4 more
3citations -
Patient-Reported Outcomes: Danicopan As Add-on Therapy to Ravulizumab or Eculizumab Versus Placebo in Patients with Paroxysmal Nocturnal Hemoglobinuria and Clinically Significant Extravascular Hemolysis2023 Blood conference-abstract Immunology and Microbiology Complement system in diseases Open access
Caroline Irene Piatek, Jong Wook Lee, Morag Griffin, Jun‐ichi Nishimura, Christopher Jordan Patriquin, Hubert Schrezenmeier, +9 more
0citations -
OP0018 Characterizing ANCA-specific B cells in ANCA-associated Vasculitis Patients2025 Annals of the Rheumatic Diseases conference-abstract Medicine Vasculitis and related conditions Open access
Laura S. van Dam, Shima Parsafar, Audra L. Horomanski, Orr Sharpe, Jolijn R. van Leeuwen, Tobias Volker Lanz, +3 more
0citations
18 results